Obstetrics/Gynecology
RSSArticles
-
New Light on the Link Between Chronic Stress and Ovarian Cancer Tumorigenesis
While stress has well documented effects on immune, neurochemical and endocrinological function, its role in cancer progression is less well understood. It is appreciated, in preclinical studies, that stress can affect the growth of some tumors through modulation of the immune response to tumor cells. -
Estrogen, Testosterone, and Breast Cancer in the Nurses' Health Study
The nurses' health study reported the risk of invasive breast cancer associated with the use of combined estrogen and testosterone. At the beginning of this cohort study, only 33 women reported testosterone use, but over the next 10 years this number increased to 550. -
Full September 2006 Issue in PDF
-
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch: Raloxifene's Role for Estrogen- and Age-Related Problems
The Truth About Multivitamins; Statins and Hepatitis C; Preventing Hot Flashes; FDA News -
Breast Cancer Risk in the WHI Estrogen-Progestin Trial Arm
Anderson and colleagues from the WHI performed subgroup analyses focusing on how prior hormone therapy use influenced the risk of breast cancer found in the estrogen-progestin trial arm. -
OB/GYNs' Attitudes Toward Hysterectomy
A survey was mailed to 500 members of the American College of Obstetricians and Gynecologists presenting a case of symptomatic fibroids. The respondents were asked to choose hysterectomy or a uterus-sparing procedure, 49% responded. -
Full October 1, 2006 Issue in PDF
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
A team from UCSF recently reviewed company documents that were entered into the public record as a result of litigation over the promotion of gabapentin (Neurontin) between 1994 and 1998.